Application YC di SFA Therapeutics

Summer 2021Active

SFA Therapeutics ha partecipato a Y Combinator nel batch Summer 2021 come azienda Healthcare. Sotto: cosa fa l'azienda, chi l'ha fondata e la sua application a YC, ricostruita domanda per domanda nel form reale di YC.

Batch YC: Summer 2021
Settore: HealthcareTherapeutics
Dimensione team: 4
Stato: Active
Lanciata: 2021

Founder

Ira SpectorFounder
Alla ArzumanyanFounder
Mark FeitelsonFounder

Cosa fa SFA Therapeutics

SFA Therapeutics is creating therapeutically-tailored oral drugs that regulate the immune system; with a focus on autoimmune diseases and cancers that originate from chronic inflammation. There are over 300 million patients who suffer from autoimmune diseases. Our treatment is designed to block the root cause of many of these chronic inflammatory diseases, with safe oral drugs. We have strong clinical data from a phase 1b clinical trial in psoriasis, and human data in pancreatic cancer, uveitis and NASH. we have a total of 9 drugs in our pipeline and 15 patents.

Application YC di SFA Therapeutics, ricostruita

Domanda per Y Combinator

SFA Therapeutics, batch Summer 2021. Le vere domande del form, risposte da dati pubblici.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

SFA Therapeutics

Describe what your company does in 50 characters or less.

Regulating the immune system to block cancer & autoimmune diseases

What is your company going to make? Please describe your product and what it does or will do.

We are developing orally-administered immunoregulators targeting chronic inflammation that drives autoimmune diseases and certain cancers. Our drugs block key immune pathways causing diseases like psoriasis, pancreatic cancer, uveitis, and NASH. We already have strong phase 1b clinical data for psoriasis and a pipeline of 9 drug candidates with 15 patents.

Where do you live now, and where would the company be based after YC?

We live and are based in Philadelphia, PA, USA. After YC, we plan to stay in Philadelphia to leverage local biotech resources and keep our team intact.

Explain your decision regarding location.

Philadelphia is where our founders are based and where we've built our scientific and clinical collaborations. It has a strong biotech community and is well suited for therapeutic development, so relocating after YC is unnecessary.

21 risposte in più nell'application completa

Founders, Progress, Idea, Equity, Curious, Batch Preference sono nella versione completa. Crea un account gratuito per aprirla in YC Insights, accanto a ogni altro batch YC.

Vedi domanda completa

Domande Frequenti

Questa è l'application YC reale di SFA Therapeutics?

No. Y Combinator mantiene private le application inviate. Questa è una ricostruzione: le domande del form YC reale, a cui si è risposto usando i dati pubblici di SFA Therapeutics (note di lancio, background dei founder, descrizione del prodotto). Mostra come un'azienda come SFA Therapeutics si presenterebbe a YC, non il testo che hanno inviato.

A quale batch YC apparteneva SFA Therapeutics?

SFA Therapeutics apparteneva al batch Summer 2021 di Y Combinator.

Chi ha fondato SFA Therapeutics?

SFA Therapeutics è stato fondato da Ira Spector, Alla Arzumanyan, Mark Feitelson.

Cosa fa SFA Therapeutics?

Regulating the immune system to block cancer & autoimmune diseases

Come leggo la ricostruzione completa della application?

Crea un account Round Funded gratuito. La versione completa di 26 risposte della application di SFA Therapeutics, e di ogni altro batch YC, è in YC Insights.